Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients

被引：28

作者：

Dvojkovic, Anja ^{[1
]}

Perkovic, Matea Nikolac ^{[2
]}

Sagud, Marina ^{[3
,4
]}

Erjavec, Gordana Nedic ^{[2
]}

Peles, Alma Mihaljevic ^{[3
,4
]}

Strac, Dubravka Svob ^{[2
]}

Cusa, Bjanka Vuksan ^{[3
,4
]}

Tudor, Lucija ^{[2
]}

Kusevic, Zorana ^{[3
,4
]}

Konjevod, Marcela ^{[2
]}

Zivkovic, Maja ^{[4
]}

Jevtovic, Sasa ^{[3
,4
]}

Pivac, Nela ^{[2
]}

机构：

[1] Univ Psychiat Hosp Vrapce, Bolnicka Cesta 32, HR-10090 Zagreb, Croatia

[2] Rudjer Boskovic Inst, Bijenicka Cesta 54, HR-10000 Zagreb, Croatia

[3] Univ Zagreb, Sch Med, Salata 3, HR-10000 Zagreb, Croatia

[4] Univ Hosp Ctr Zagreb, Dept Psychiat & Psychol Med, Zagreb, Croatia

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2021年 / 105卷

关键词：

Depression; Escitalopram; Plasma BDNF; Platelet serotonin; Patients; Vortioxetine; PERIPHERAL BIOCHEMICAL MARKERS; NEUROTROPHIC FACTOR LEVELS; MAJOR DEPRESSION; ANTIDEPRESSANT VORTIOXETINE; BLOOD-BRAIN; SHORT-TERM; SERUM; PAROXETINE; DISORDER; BIOMARKER;

D O I：

10.1016/j.pnpbp.2020.110016

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Escitalopram and vortioxetine are efficacious antidepressants. They directly target serotonin (5-HT) system, but vortioxetine mechanism of action is distinct from the one of selective serotonin reuptake inhibitors (SSRIs). Treatment with SSRIs decrease platelet 5-HT concentration and increase peripheral brain-derived neurotrophic factor (BDNF) levels. Since vortioxetine has a multimodal mechanism of action, it is expected to have a greater effect on circulatory BDNF concentration, compared to conventional antidepressants. This longitudinal study aimed to explore and compare the effects of 4-weeks of treatment with vortioxetine and escitalopram on plasma BDNF and platelet 5-HT concentration in patients with major depressive disorder (MDD). The results revealed that vortioxetine significantly increased plasma BDNF concentration (p = .018) and significantly decreased platelet 5-HT concentration (p < .001). Treatment with escitalopram significantly decreased platelet 5-HT concentration (p < .001), but it did not affect plasma BDNF concentration (p = .379). Response to vortioxetine was not predicted by baseline plasma BDNF or platelet 5-HT concentration, but response to escitalopram was predicted by baseline platelet 5-HT concentration. These effects might be due to vortioxetine unique mechanism of action, but the clinical implications are unclear. It remains to be determined whether this finding extends during long-term vortioxetine treatment, and which, if any, clinical effects emerge from BDNF increase.

引用

页数：11

共 50 条

[41] The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood [J].

Madsen, Clara A. ;

Navarro, Miriam L. ;

Elfving, Betina ;

Kessing, Lars, V ;

Castren, Eero ;

Mikkelsen, Jens D. ;

Knudsen, Gitte M. .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 87 :35-55

[42] Plasma and serum brain-derived neurotrophic factor depressed patients during 1 year of antidepressant (BDNF) in treatments [J].

Piccinni, Armando ;

Marazziti, Donatella ;

Catena, Mario ;

Domenici, Luciano ;

Del Debbio, Alessandro ;

Bianchi, Carolina ;

Mannari, Claudio ;

Martini, Claudia ;

Da Pozzo, Eleonora ;

Schiavi, Elisa ;

Mariotti, Alessandra ;

Roncaglia, Isabella ;

Palla, Agnese ;

Consoli, Giorgio ;

Giovannini, Luca ;

Massimetti, Gabriele ;

Dell'Osso, Liliana .

JOURNAL OF AFFECTIVE DISORDERS, 2008, 105 (1-3) :279-283

[43] Effects of Two Selective Serotonin Reuptake Inhibitor Antidepressants, Sertraline and Escitalopram, on Aldosterone/Renin Ratio in Normotensive Depressed Male Patients [J].

Ahmed, Ashraf H. ;

Calvird, Michele ;

Gordon, Richard D. ;

Taylor, Paul J. ;

Ward, Gregory ;

Pimenta, Eduardo ;

Young, Ross ;

Stowasser, Michael .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1039-1045

[44] Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients [J].

Mück-Seler, D ;

Pivac, N ;

Jakovljevic, M ;

Brzovic, Z .

BIOLOGICAL PSYCHIATRY, 1999, 45 (11) :1433-1439

[45] Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients [J].

Konopka, LM ;

Cooper, R ;

Crayton, JW .

BIOLOGICAL PSYCHIATRY, 1996, 39 (08) :708-713

[46] The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression [J].

Marina Sagud ;

Nela Pivac ;

Maja Mustapic ;

Gordana Nedic ;

Alma Mihaljevic Peles ;

Milivoj Kramaric ;

Miro Jakovljevic ;

Dorotea Muck-Seler .

Psychopharmacology, 2008, 197 :683-685

[47] High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline [J].

Franke, L ;

Schewe, HJ ;

Uebelhack, R ;

Müller-Oerlinghausen, B .

NEUROSCIENCE LETTERS, 2003, 345 (02) :105-108

[48] The effect of clinical outcome on platelet G proteins of major depressed patients [J].

Karege, F ;

Bovier, P ;

Stepanian, R ;

Malafosse, A .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (02) :89-94

[49] Development and validation of UHPLC-MS/MS method for simultaneous quantification of escitalopram and its major metabolites in human plasma and its application in depressed patients [J].

Hu, Zhanhua ;

Li, Jiali ;

Xiao, Aixiang ;

Zheng, Juntao ;

Guan, Shaoxing ;

Guo, Jianxiong ;

Huang, Min .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 217

[50] Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation vs. Escitalopram for Patients With Mild-to-Moderate Depression (TECAS): Study Design for a Randomized Controlled, Non-inferiority Trial [J].

Yang, Sichang ;

Qin, Zongshi ;

Yang, Xinjing ;

Chan, Mei Yan ;

Zhang, Shuiyan ;

Rong, Peijing ;

Hou, Xiaobing ;

Jin, Guixing ;

Xu, Fengquan ;

Liu, Yong ;

Zhang, Zhang-Jin .

FRONTIERS IN PSYCHIATRY, 2022, 13

← 1 2 3 4 5 →